Price
$4.87-5.07%Social Signal Score
Analyst Ratings
11 analystsRevenue
$320.11M-47.02%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Ryan S. Napierski
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Employees
- 2,800
- Beta
- 0.96
- Country
- US
- Piotroski score
- 4 / 9 (Middling)
- Altman Z-score
- 3.70
Financials
Revenue
$320.11M-47.0%Net Income
$-249.80M-539.2%EBITDA
$-47.20M-146.7%Free Cash Flow
$4.99M-87.3%EPS (diluted)
$-5.14-624.5%Shares Outstanding (diluted)
48.60M-16.0%Operating Expenses
$198.77MCash & Debt
$189.64MReturn of Capital
$2.91MRevenue by Segment (annual)
$224.72MDividend per Share
$0.06Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $1.49B | $160.20M | $3.25 |
| 2024 | $1.73B | $-146.59M | $-2.95 |
| 2023 | $1.97B | $8.60M | $0.17 |
| 2022 | $2.23B | $104.78M | $2.10 |
| 2021 | $2.70B | $147.27M | $2.93 |
| 2020 | $2.58B | $191.35M | $3.66 |
| 2019 | $2.42B | $173.55M | $3.13 |
| 2018 | $2.68B | $121.89M | $2.21 |
| 2017 | $2.28B | $129.44M | $2.45 |
| 2016 | $2.21B | $143.09M | $2.58 |
| 2015 | $2.25B | $133.05M | $2.29 |
| 2014 | $2.57B | $189.18M | $3.20 |
| 2013 | $3.18B | $364.89M | $6.23 |
| 2012 | $2.17B | $221.65M | $3.66 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from NUS's reported EPS growth of -0.9% a year over 13 years.
- EPS in 5 years
- $3.11
- Implied price
- $55.92
- Return from $4.62
- 64.7% a year
To earn 15.0% a year on these assumptions you'd need to buy at $27.80 — today's price is already 83.4% below that.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 12 | 15 | 18 | 21 | 24 |
|---|---|---|---|---|---|
| -10.9% | 36.5% | 42.7% | 48.0% | 52.7% | 56.8% |
| -5.9% | 44.2% | 50.7% | 56.3% | 61.2% | 65.6% |
| -0.9% | 51.8% | 58.8% | 64.7% | 69.8% | 74.4% |
| 4.1% | 59.5% | 66.8% | 73.0% | 78.4% | 83.2% |
| 9.1% | 67.2% | 74.8% | 81.3% | 86.9% | 92.0% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
60-25.77%Social Signal Score
Mentions (8)
- Newsbusinesswire.com·32d ago·Positive
Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS), a global beauty and wellness leader, has been ranked the world's No. 1 company for beauty and wellness device systems by Euromonitor International Ltd. for the third consecutive year.* “Being recognized by Euromonitor is a powerful validation of our long-term vision and commitment to innovation,” said Ryan Napierski, Nu Skin p…
View source ↗ - Newsglobenewswire.com·43d ago·Neutral
STMicroelectronics and NUS launch Corporate Lab to power the future of Edge AI in Singapore STMicroelectronics and NUS launch Corporate Lab to power the future of Edge AI in Singapore HELIX joint R&D initiative to enable new generative and embodied AI use cases at the edge through system-to-silicon innovation Research will focus on memory-centric architectures, innovative in-memory computing, scalable compute-and-memory systems, and advanced silicon and embedded-memory technologies Corporate Lab…
View source ↗ - Newsnewsfilecorp.com·55d ago·Neutral
Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 2Q26 Dallas, Texas--(Newsfile Corp. - August 11, 2026) - NU Skin Enterprises Inc. (NYSE: NUS): Stonegate Capital Partners updates their coverage on NU Skin Enterprises Inc. (NYSE: NUS). NUS reported revenue, adj NI, and adj EPS of $320.1M, $10.0M, and $0.20, respectively.
View source ↗ - Newszacks.com·55d ago·Neutral
Nu Skin Enterprises Q2 Earnings Meet Estimates, Revenues Down Y/Y NUS' second-quarter revenues fall 17.1% and EPS drops 53.5%, while it cuts the 2026 revenue and adjusted EPS outlooks.
View source ↗ - Newsseekingalpha.com·56d ago·Positive
Nu Skin Enterprises, Inc. (NUS) Q2 2026 Earnings Call Transcript Nu Skin Enterprises, Inc. (NUS) Q2 2026 Earnings Call Transcript
View source ↗ - Newsmarketbeat.com·56d ago·Neutral
Nu Skin Enterprises Q2 Earnings Call Highlights Nu Skin Enterprises NYSE: NUS reported second-quarter revenue of $320.1 million and adjusted earnings per share of $0.20, as the company continued the rollout of its Prysm iO wellness platform and pursued cost and margin initiatives.
View source ↗ - Newszacks.com·56d ago·Neutral
Nu Skin Enterprises (NUS) Matches Q2 Earnings Estimates Nu Skin Enterprises (NUS) came out with quarterly earnings of $0.2 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.43 per share a year ago.
View source ↗ - Newsbusinesswire.com·56d ago·Neutral
Nu Skin Enterprises Reports Second Quarter Results PROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS) today announced second quarter results. Executive Summary Q2 2026 vs. Prior-year Quarter Revenue $320.1 million; (17.1)% (1.0)% FX impact or $(4.0) million Earnings Per Share (EPS) $(5.14) or $0.20 excluding non-cash impairment and non-cash tax charges compared to $0.43 Customers 660,037; (14)% Paid Affiliates 120,291; (8)% Sales Leaders 26,998; (9)% “We continue to make progress
View source ↗
Earnings
Thu, Nov 5(in 4 weeks)
Consensus estimate $0.21 per share
Typical surprise +13.3% (median, so one quarter with a near-zero estimate can't distort it)
- Mon, Aug 10$0.20 vs $0.20beat
- Thu, May 7$0.14 vs $0.15miss
- Thu, Feb 12$0.29 vs $0.30miss
- Thu, Nov 6$0.34 vs $0.30beat
- Thu, Aug 7$0.43 vs $0.25beat
- Thu, May 8$0.23 vs $0.15beat
Estimates and results for NUS via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by NUS officers and directors.
- Bought
- $102k
- Sold
- $891k
2 trades
11 trades
- Nathanson Laurasold
- Hatchett Steven Keithbought
- Nathanson Laurasold
- Clark Chayce Davidsold
- Campbell Daniel Wsold
- Campbell Daniel Wsold
- Woodbury Edwina Dsold
- Battle Emma S.sold
87 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in NUS.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.